Surveillance for Infection and Colonization due to Candida spp. at a Tertiary Referral Hospital in Botswana: 2022-2024 Article Swipe
Ms Teresia Gatonye
,
Ms Janet John-Thubuka
,
Mr Tichaona Machiya
,
Ms Tlhalefo Dudu Ntereke
,
Mr Tshiamo Zankere
,
Mathias Tembo
,
Ms Boingotlo Gopolang
,
Dr Naledi Mannathoko
,
Ms Miriam Mwamba
,
Pradeep Govender
,
Mamadou Jallow
,
Ms Rudzani Mashau
,
Ms Ruth Mpembe
,
Ms Silondiwe Nzimande
,
Dr Melissa Richard-Greenblatt
,
David S. Goldfarb
,
Dr Ebbing Lautenbach
,
Dr Jonathan Strysko
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.ijid.2024.107730
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.ijid.2024.107730
Introduction: Candida spp. are a common cause of healthcare-associated infections globally and Candida bloodstream infections (BSI) are associated with ∼30% mortality. Candida auris, a multidrug-resistant yeast which can be challenging to detect using traditional laboratory methods, was first reported in Botswana in 2022. This study aimed to analyze surveillance data to characterize patterns of Candida BSI and colonization among hospitalized patients in Botswana. Methods: We reviewed microbiology surveillance records over a 16-month period (October 2022 – January 2024) from a 530-bed tertiary referral hospital in Botswana. Blood cultures were collected per routine work-up for sepsis, incubated in an automated system (BacT/ALERT, bioMérieux), and identified using a combination of manual and automated methods (e.g. VITEK 2). Colonization samples (skin and perirectal swabs) were collected during twice-monthly point prevalence surveys in the hospital's intensive care unit (ICU) and neonatal intensive care unit (NICU), transported in ESwab media (COPAN Diagnostics), and cultured with chromogenic media (CHROMagar, Candida Plus). Identification of preserved presumptive Candida spp. isolates from both BSIs and colonization samples was confirmed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) at the National Institute for Communicable Diseases, South Africa. Results: A total of 70 Candida BSI were detected during the surveillance period, making it the 6th leading cause of BSI (995 all-cause BSIs detected from a total of 6895 blood cultures). Of 43 preserved BSI isolates which underwent confirmation, C. albicans was most commonly identified species (20%), followed by C. auris (17%), C. krusei (15%), C. parapsilosis (10%) and C. glabrata (10%) (Figure 1). Among 190 samples collected from ICU, Candida colonization was identified from 181 (95%) patient samples, most commonly C. albicans (35% of 181), followed by C. auris (32% of 181). Among 116 samples collected from ICU, Candida colonization was identified from 103 (89%) patient samples, most commonly C. albicans (56% of 103), followed by C. parapsilosis (17% of 103). The relative frequency of Candida spp. causing BSI [data not shown] roughly aligned with the species identified through concurrent colonization screening, with the exception of C. krusei, which can be attributed to a neonatal C. krusei outbreak linked to contaminated medication (Figure 2). Discussion: Candida spp. accounted for a significant portion of BSIs at this hospital and were responsible for at least one hospital outbreak during this time period. The repeated detection of C. auris among hospitalized patients, including neonates, over several months demonstrates the potential for sustained transmission. Conclusion: Routine colonization screening may serve as an early signal for disease transmission and help in the development of targeted containment strategies by infection prevention/control teams. Further analysis with whole genome sequencing could be used to produce a phylogenetic comparison with other clinical isolates in the southern African region.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.ijid.2024.107730
- https://doi.org/10.1016/j.ijid.2024.107730
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4408046382
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4408046382Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.ijid.2024.107730Digital Object Identifier
- Title
-
Surveillance for Infection and Colonization due to Candida spp. at a Tertiary Referral Hospital in Botswana: 2022-2024Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-02-28Full publication date if available
- Authors
-
Ms Teresia Gatonye, Ms Janet John-Thubuka, Mr Tichaona Machiya, Ms Tlhalefo Dudu Ntereke, Mr Tshiamo Zankere, Mathias Tembo, Ms Boingotlo Gopolang, Dr Naledi Mannathoko, Ms Miriam Mwamba, Pradeep Govender, Mamadou Jallow, Ms Rudzani Mashau, Ms Ruth Mpembe, Ms Silondiwe Nzimande, Dr Melissa Richard-Greenblatt, David S. Goldfarb, Dr Ebbing Lautenbach, Dr Jonathan StryskoList of authors in order
- Landing page
-
https://doi.org/10.1016/j.ijid.2024.107730Publisher landing page
- PDF URL
-
https://doi.org/10.1016/j.ijid.2024.107730Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.ijid.2024.107730Direct OA link when available
- Concepts
-
Colonization, Tertiary referral hospital, Referral, Medicine, Microbiology, Tertiary referral centre, Internal medicine, Biology, Family medicine, Retrospective cohort studyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4408046382 |
|---|---|
| doi | https://doi.org/10.1016/j.ijid.2024.107730 |
| ids.doi | https://doi.org/10.1016/j.ijid.2024.107730 |
| ids.openalex | https://openalex.org/W4408046382 |
| fwci | 0.0 |
| type | article |
| title | Surveillance for Infection and Colonization due to Candida spp. at a Tertiary Referral Hospital in Botswana: 2022-2024 |
| biblio.issue | |
| biblio.volume | 152 |
| biblio.last_page | 107730 |
| biblio.first_page | 107730 |
| topics[0].id | https://openalex.org/T10833 |
| topics[0].field.id | https://openalex.org/fields/33 |
| topics[0].field.display_name | Social Sciences |
| topics[0].score | 0.9550999999046326 |
| topics[0].domain.id | https://openalex.org/domains/2 |
| topics[0].domain.display_name | Social Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/3306 |
| topics[0].subfield.display_name | Health |
| topics[0].display_name | Vaccine Coverage and Hesitancy |
| topics[1].id | https://openalex.org/T10912 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9550999999046326 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2739 |
| topics[1].subfield.display_name | Public Health, Environmental and Occupational Health |
| topics[1].display_name | Telemedicine and Telehealth Implementation |
| topics[2].id | https://openalex.org/T11446 |
| topics[2].field.id | https://openalex.org/fields/36 |
| topics[2].field.display_name | Health Professions |
| topics[2].score | 0.9514999985694885 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/3600 |
| topics[2].subfield.display_name | General Health Professions |
| topics[2].display_name | Mobile Health and mHealth Applications |
| is_xpac | False |
| apc_list.value | 1750 |
| apc_list.currency | USD |
| apc_list.value_usd | 1750 |
| apc_paid.value | 1750 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 1750 |
| concepts[0].id | https://openalex.org/C2776927270 |
| concepts[0].level | 2 |
| concepts[0].score | 0.8765649795532227 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q815962 |
| concepts[0].display_name | Colonization |
| concepts[1].id | https://openalex.org/C2780283434 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6744769215583801 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q7705274 |
| concepts[1].display_name | Tertiary referral hospital |
| concepts[2].id | https://openalex.org/C2776135927 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6306891441345215 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q5242559 |
| concepts[2].display_name | Referral |
| concepts[3].id | https://openalex.org/C71924100 |
| concepts[3].level | 0 |
| concepts[3].score | 0.5381036996841431 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[3].display_name | Medicine |
| concepts[4].id | https://openalex.org/C89423630 |
| concepts[4].level | 1 |
| concepts[4].score | 0.411375492811203 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7193 |
| concepts[4].display_name | Microbiology |
| concepts[5].id | https://openalex.org/C2910763605 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4104359447956085 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7705274 |
| concepts[5].display_name | Tertiary referral centre |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.3025122284889221 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C86803240 |
| concepts[7].level | 0 |
| concepts[7].score | 0.17102938890457153 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[7].display_name | Biology |
| concepts[8].id | https://openalex.org/C512399662 |
| concepts[8].level | 1 |
| concepts[8].score | 0.13965213298797607 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[8].display_name | Family medicine |
| concepts[9].id | https://openalex.org/C167135981 |
| concepts[9].level | 2 |
| concepts[9].score | 0.0551266074180603 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2146302 |
| concepts[9].display_name | Retrospective cohort study |
| keywords[0].id | https://openalex.org/keywords/colonization |
| keywords[0].score | 0.8765649795532227 |
| keywords[0].display_name | Colonization |
| keywords[1].id | https://openalex.org/keywords/tertiary-referral-hospital |
| keywords[1].score | 0.6744769215583801 |
| keywords[1].display_name | Tertiary referral hospital |
| keywords[2].id | https://openalex.org/keywords/referral |
| keywords[2].score | 0.6306891441345215 |
| keywords[2].display_name | Referral |
| keywords[3].id | https://openalex.org/keywords/medicine |
| keywords[3].score | 0.5381036996841431 |
| keywords[3].display_name | Medicine |
| keywords[4].id | https://openalex.org/keywords/microbiology |
| keywords[4].score | 0.411375492811203 |
| keywords[4].display_name | Microbiology |
| keywords[5].id | https://openalex.org/keywords/tertiary-referral-centre |
| keywords[5].score | 0.4104359447956085 |
| keywords[5].display_name | Tertiary referral centre |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.3025122284889221 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/biology |
| keywords[7].score | 0.17102938890457153 |
| keywords[7].display_name | Biology |
| keywords[8].id | https://openalex.org/keywords/family-medicine |
| keywords[8].score | 0.13965213298797607 |
| keywords[8].display_name | Family medicine |
| keywords[9].id | https://openalex.org/keywords/retrospective-cohort-study |
| keywords[9].score | 0.0551266074180603 |
| keywords[9].display_name | Retrospective cohort study |
| language | en |
| locations[0].id | doi:10.1016/j.ijid.2024.107730 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S35071406 |
| locations[0].source.issn | 1201-9712, 1878-3511 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1201-9712 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | International Journal of Infectious Diseases |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | https://doi.org/10.1016/j.ijid.2024.107730 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | International Journal of Infectious Diseases |
| locations[0].landing_page_url | https://doi.org/10.1016/j.ijid.2024.107730 |
| locations[1].id | pmh:oai:doaj.org/article:3f50505e51a54c2db9eb502c1d468c48 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306401280 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[1].source.host_organization | |
| locations[1].source.host_organization_name | |
| locations[1].source.host_organization_lineage | |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | article |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | International Journal of Infectious Diseases, Vol 152, Iss , Pp 107730- (2025) |
| locations[1].landing_page_url | https://doaj.org/article/3f50505e51a54c2db9eb502c1d468c48 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5116458773 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Ms Teresia Gatonye |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ms Teresia Gatonye |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5116458780 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Ms Janet John-Thubuka |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Ms Janet John-Thubuka |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5116458781 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Mr Tichaona Machiya |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Mr Tichaona Machiya |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5116458782 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Ms Tlhalefo Dudu Ntereke |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Ms Tlhalefo Dudu Ntereke |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5116458783 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Mr Tshiamo Zankere |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Mr Tshiamo Zankere |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5063047417 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-5047-6723 |
| authorships[5].author.display_name | Mathias Tembo |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Mrs Chimwemwe V Tembo |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5116458784 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Ms Boingotlo Gopolang |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Ms Boingotlo Gopolang |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5116458785 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Dr Naledi Mannathoko |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Dr Naledi Mannathoko |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5116458786 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Ms Miriam Mwamba |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Ms Miriam Mwamba |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5085415179 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Pradeep Govender |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Prof Nelesh Govender |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5020675384 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-9748-8492 |
| authorships[10].author.display_name | Mamadou Jallow |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Ms Sabelle Jallow |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5116458774 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Ms Rudzani Mashau |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Ms Rudzani Mashau |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5116458775 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Ms Ruth Mpembe |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Ms Ruth Mpembe |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5116458776 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Ms Silondiwe Nzimande |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Ms Silondiwe Nzimande |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5116458777 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Dr Melissa Richard-Greenblatt |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Dr Melissa Richard-Greenblatt |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5088302147 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-9215-1273 |
| authorships[15].author.display_name | David S. Goldfarb |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Dr David Goldfarb |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5116458778 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Dr Ebbing Lautenbach |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Dr Ebbing Lautenbach |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5116458779 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | Dr Jonathan Strysko |
| authorships[17].author_position | last |
| authorships[17].raw_author_name | Dr Jonathan Strysko |
| authorships[17].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.ijid.2024.107730 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Surveillance for Infection and Colonization due to Candida spp. at a Tertiary Referral Hospital in Botswana: 2022-2024 |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10833 |
| primary_topic.field.id | https://openalex.org/fields/33 |
| primary_topic.field.display_name | Social Sciences |
| primary_topic.score | 0.9550999999046326 |
| primary_topic.domain.id | https://openalex.org/domains/2 |
| primary_topic.domain.display_name | Social Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/3306 |
| primary_topic.subfield.display_name | Health |
| primary_topic.display_name | Vaccine Coverage and Hesitancy |
| related_works | https://openalex.org/W2767483940, https://openalex.org/W3008142684, https://openalex.org/W3010207116, https://openalex.org/W4200089700, https://openalex.org/W2047996914, https://openalex.org/W2333913994, https://openalex.org/W4399250730, https://openalex.org/W2096068912, https://openalex.org/W2594607437, https://openalex.org/W2974433554 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1016/j.ijid.2024.107730 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S35071406 |
| best_oa_location.source.issn | 1201-9712, 1878-3511 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1201-9712 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | International Journal of Infectious Diseases |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://doi.org/10.1016/j.ijid.2024.107730 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | International Journal of Infectious Diseases |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.ijid.2024.107730 |
| primary_location.id | doi:10.1016/j.ijid.2024.107730 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S35071406 |
| primary_location.source.issn | 1201-9712, 1878-3511 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1201-9712 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | International Journal of Infectious Diseases |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | https://doi.org/10.1016/j.ijid.2024.107730 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | International Journal of Infectious Diseases |
| primary_location.landing_page_url | https://doi.org/10.1016/j.ijid.2024.107730 |
| publication_date | 2025-02-28 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.A | 188 |
| abstract_inverted_index.a | 4, 23, 70, 79, 105, 213, 342, 358, 436 |
| abstract_inverted_index.43 | 220 |
| abstract_inverted_index.70 | 191 |
| abstract_inverted_index.C. | 227, 237, 240, 243, 247, 269, 276, 298, 305, 335, 344, 383 |
| abstract_inverted_index.Of | 219 |
| abstract_inverted_index.We | 64 |
| abstract_inverted_index.an | 97, 406 |
| abstract_inverted_index.as | 405 |
| abstract_inverted_index.at | 178, 363, 370 |
| abstract_inverted_index.be | 28, 339, 432 |
| abstract_inverted_index.by | 236, 275, 304, 421 |
| abstract_inverted_index.in | 39, 41, 61, 84, 96, 128, 142, 414, 443 |
| abstract_inverted_index.it | 201 |
| abstract_inverted_index.of | 7, 53, 107, 156, 190, 206, 215, 272, 279, 301, 308, 313, 334, 361, 382, 417 |
| abstract_inverted_index.to | 30, 46, 50, 341, 348, 434 |
| abstract_inverted_index.1). | 251 |
| abstract_inverted_index.103 | 292 |
| abstract_inverted_index.116 | 282 |
| abstract_inverted_index.181 | 263 |
| abstract_inverted_index.190 | 253 |
| abstract_inverted_index.2). | 114, 352 |
| abstract_inverted_index.6th | 203 |
| abstract_inverted_index.BSI | 55, 193, 207, 222, 317 |
| abstract_inverted_index.The | 310, 379 |
| abstract_inverted_index.and | 11, 56, 102, 109, 118, 135, 147, 165, 246, 366, 412 |
| abstract_inverted_index.are | 3, 16 |
| abstract_inverted_index.can | 27, 338 |
| abstract_inverted_index.for | 93, 182, 357, 369, 396, 409 |
| abstract_inverted_index.may | 403 |
| abstract_inverted_index.not | 319 |
| abstract_inverted_index.one | 372 |
| abstract_inverted_index.per | 90 |
| abstract_inverted_index.the | 129, 179, 197, 202, 324, 332, 394, 415, 444 |
| abstract_inverted_index.was | 36, 168, 229, 260, 289 |
| abstract_inverted_index.– | 75 |
| abstract_inverted_index.(17% | 307 |
| abstract_inverted_index.(32% | 278 |
| abstract_inverted_index.(35% | 271 |
| abstract_inverted_index.(56% | 300 |
| abstract_inverted_index.(995 | 208 |
| abstract_inverted_index.2022 | 74 |
| abstract_inverted_index.6895 | 216 |
| abstract_inverted_index.BSIs | 164, 210, 362 |
| abstract_inverted_index.ICU, | 257, 286 |
| abstract_inverted_index.This | 43 |
| abstract_inverted_index.both | 163 |
| abstract_inverted_index.care | 132, 138 |
| abstract_inverted_index.data | 49 |
| abstract_inverted_index.from | 78, 162, 212, 256, 262, 285, 291 |
| abstract_inverted_index.help | 413 |
| abstract_inverted_index.mass | 175 |
| abstract_inverted_index.most | 230, 267, 296 |
| abstract_inverted_index.over | 69, 390 |
| abstract_inverted_index.spp. | 2, 160, 315, 355 |
| abstract_inverted_index.this | 364, 376 |
| abstract_inverted_index.time | 377 |
| abstract_inverted_index.unit | 133, 139 |
| abstract_inverted_index.used | 433 |
| abstract_inverted_index.were | 88, 121, 194, 367 |
| abstract_inverted_index.with | 18, 149, 323, 331, 427, 439 |
| abstract_inverted_index.(10%) | 245, 249 |
| abstract_inverted_index.(89%) | 293 |
| abstract_inverted_index.(95%) | 264 |
| abstract_inverted_index.(BSI) | 15 |
| abstract_inverted_index.(ICU) | 134 |
| abstract_inverted_index.(e.g. | 112 |
| abstract_inverted_index.(skin | 117 |
| abstract_inverted_index.103), | 302 |
| abstract_inverted_index.103). | 309 |
| abstract_inverted_index.181), | 273 |
| abstract_inverted_index.181). | 280 |
| abstract_inverted_index.2022. | 42 |
| abstract_inverted_index.2024) | 77 |
| abstract_inverted_index.Among | 252, 281 |
| abstract_inverted_index.Blood | 86 |
| abstract_inverted_index.ESwab | 143 |
| abstract_inverted_index.South | 185 |
| abstract_inverted_index.VITEK | 113 |
| abstract_inverted_index.[data | 318 |
| abstract_inverted_index.aimed | 45 |
| abstract_inverted_index.among | 58, 385 |
| abstract_inverted_index.auris | 238, 277, 384 |
| abstract_inverted_index.blood | 217 |
| abstract_inverted_index.cause | 6, 205 |
| abstract_inverted_index.could | 431 |
| abstract_inverted_index.early | 407 |
| abstract_inverted_index.first | 37 |
| abstract_inverted_index.laser | 172 |
| abstract_inverted_index.least | 371 |
| abstract_inverted_index.media | 144, 151 |
| abstract_inverted_index.other | 440 |
| abstract_inverted_index.point | 125 |
| abstract_inverted_index.serve | 404 |
| abstract_inverted_index.study | 44 |
| abstract_inverted_index.total | 189, 214 |
| abstract_inverted_index.using | 32, 104, 170 |
| abstract_inverted_index.which | 26, 224, 337 |
| abstract_inverted_index.whole | 428 |
| abstract_inverted_index.yeast | 25 |
| abstract_inverted_index.(15%), | 242 |
| abstract_inverted_index.(17%), | 239 |
| abstract_inverted_index.(20%), | 234 |
| abstract_inverted_index.(COPAN | 145 |
| abstract_inverted_index.Plus). | 154 |
| abstract_inverted_index.auris, | 22 |
| abstract_inverted_index.common | 5 |
| abstract_inverted_index.detect | 31 |
| abstract_inverted_index.during | 123, 196, 375 |
| abstract_inverted_index.genome | 429 |
| abstract_inverted_index.krusei | 241, 345 |
| abstract_inverted_index.linked | 347 |
| abstract_inverted_index.making | 200 |
| abstract_inverted_index.manual | 108 |
| abstract_inverted_index.months | 392 |
| abstract_inverted_index.period | 72 |
| abstract_inverted_index.shown] | 320 |
| abstract_inverted_index.signal | 408 |
| abstract_inverted_index.swabs) | 120 |
| abstract_inverted_index.system | 99 |
| abstract_inverted_index.teams. | 424 |
| abstract_inverted_index.∼30% | 19 |
| abstract_inverted_index.(Figure | 250, 351 |
| abstract_inverted_index.(NICU), | 140 |
| abstract_inverted_index.530-bed | 80 |
| abstract_inverted_index.Africa. | 186 |
| abstract_inverted_index.African | 446 |
| abstract_inverted_index.Candida | 1, 12, 21, 54, 153, 159, 192, 258, 287, 314, 354 |
| abstract_inverted_index.Further | 425 |
| abstract_inverted_index.January | 76 |
| abstract_inverted_index.Routine | 400 |
| abstract_inverted_index.aligned | 322 |
| abstract_inverted_index.analyze | 47 |
| abstract_inverted_index.causing | 316 |
| abstract_inverted_index.disease | 410 |
| abstract_inverted_index.krusei, | 336 |
| abstract_inverted_index.leading | 204 |
| abstract_inverted_index.methods | 111 |
| abstract_inverted_index.patient | 265, 294 |
| abstract_inverted_index.period, | 199 |
| abstract_inverted_index.period. | 378 |
| abstract_inverted_index.portion | 360 |
| abstract_inverted_index.produce | 435 |
| abstract_inverted_index.records | 68 |
| abstract_inverted_index.region. | 447 |
| abstract_inverted_index.roughly | 321 |
| abstract_inverted_index.routine | 91 |
| abstract_inverted_index.samples | 116, 167, 254, 283 |
| abstract_inverted_index.sepsis, | 94 |
| abstract_inverted_index.several | 391 |
| abstract_inverted_index.species | 233, 325 |
| abstract_inverted_index.surveys | 127 |
| abstract_inverted_index.through | 327 |
| abstract_inverted_index.work-up | 92 |
| abstract_inverted_index.(October | 73 |
| abstract_inverted_index.16-month | 71 |
| abstract_inverted_index.Botswana | 40 |
| abstract_inverted_index.Methods: | 63 |
| abstract_inverted_index.National | 180 |
| abstract_inverted_index.Results: | 187 |
| abstract_inverted_index.albicans | 228, 270, 299 |
| abstract_inverted_index.analysis | 426 |
| abstract_inverted_index.clinical | 441 |
| abstract_inverted_index.commonly | 231, 268, 297 |
| abstract_inverted_index.cultured | 148 |
| abstract_inverted_index.cultures | 87 |
| abstract_inverted_index.detected | 195, 211 |
| abstract_inverted_index.followed | 235, 274, 303 |
| abstract_inverted_index.glabrata | 248 |
| abstract_inverted_index.globally | 10 |
| abstract_inverted_index.hospital | 83, 365, 373 |
| abstract_inverted_index.isolates | 161, 223, 442 |
| abstract_inverted_index.methods, | 35 |
| abstract_inverted_index.neonatal | 136, 343 |
| abstract_inverted_index.outbreak | 346, 374 |
| abstract_inverted_index.patients | 60 |
| abstract_inverted_index.patterns | 52 |
| abstract_inverted_index.referral | 82 |
| abstract_inverted_index.relative | 311 |
| abstract_inverted_index.repeated | 380 |
| abstract_inverted_index.reported | 38 |
| abstract_inverted_index.reviewed | 65 |
| abstract_inverted_index.samples, | 266, 295 |
| abstract_inverted_index.southern | 445 |
| abstract_inverted_index.targeted | 418 |
| abstract_inverted_index.tertiary | 81 |
| abstract_inverted_index.Botswana. | 62, 85 |
| abstract_inverted_index.Diseases, | 184 |
| abstract_inverted_index.Institute | 181 |
| abstract_inverted_index.accounted | 356 |
| abstract_inverted_index.all-cause | 209 |
| abstract_inverted_index.automated | 98, 110 |
| abstract_inverted_index.collected | 89, 122, 255, 284 |
| abstract_inverted_index.confirmed | 169 |
| abstract_inverted_index.detection | 381 |
| abstract_inverted_index.exception | 333 |
| abstract_inverted_index.frequency | 312 |
| abstract_inverted_index.including | 388 |
| abstract_inverted_index.incubated | 95 |
| abstract_inverted_index.infection | 422 |
| abstract_inverted_index.intensive | 131, 137 |
| abstract_inverted_index.neonates, | 389 |
| abstract_inverted_index.patients, | 387 |
| abstract_inverted_index.potential | 395 |
| abstract_inverted_index.preserved | 157, 221 |
| abstract_inverted_index.screening | 402 |
| abstract_inverted_index.sustained | 397 |
| abstract_inverted_index.underwent | 225 |
| abstract_inverted_index.associated | 17 |
| abstract_inverted_index.attributed | 340 |
| abstract_inverted_index.comparison | 438 |
| abstract_inverted_index.concurrent | 328 |
| abstract_inverted_index.cultures). | 218 |
| abstract_inverted_index.hospital's | 130 |
| abstract_inverted_index.identified | 103, 232, 261, 290, 326 |
| abstract_inverted_index.infections | 9, 14 |
| abstract_inverted_index.laboratory | 34 |
| abstract_inverted_index.medication | 350 |
| abstract_inverted_index.mortality. | 20 |
| abstract_inverted_index.perirectal | 119 |
| abstract_inverted_index.prevalence | 126 |
| abstract_inverted_index.screening, | 330 |
| abstract_inverted_index.sequencing | 430 |
| abstract_inverted_index.strategies | 420 |
| abstract_inverted_index.(CHROMagar, | 152 |
| abstract_inverted_index.Conclusion: | 399 |
| abstract_inverted_index.Discussion: | 353 |
| abstract_inverted_index.bloodstream | 13 |
| abstract_inverted_index.challenging | 29 |
| abstract_inverted_index.chromogenic | 150 |
| abstract_inverted_index.combination | 106 |
| abstract_inverted_index.containment | 419 |
| abstract_inverted_index.development | 416 |
| abstract_inverted_index.presumptive | 158 |
| abstract_inverted_index.responsible | 368 |
| abstract_inverted_index.significant | 359 |
| abstract_inverted_index.traditional | 33 |
| abstract_inverted_index.transported | 141 |
| abstract_inverted_index.(BacT/ALERT, | 100 |
| abstract_inverted_index.Colonization | 115 |
| abstract_inverted_index.Communicable | 183 |
| abstract_inverted_index.characterize | 51 |
| abstract_inverted_index.colonization | 57, 166, 259, 288, 329, 401 |
| abstract_inverted_index.contaminated | 349 |
| abstract_inverted_index.demonstrates | 393 |
| abstract_inverted_index.hospitalized | 59, 386 |
| abstract_inverted_index.microbiology | 66 |
| abstract_inverted_index.parapsilosis | 244, 306 |
| abstract_inverted_index.phylogenetic | 437 |
| abstract_inverted_index.spectrometry | 176 |
| abstract_inverted_index.surveillance | 48, 67, 198 |
| abstract_inverted_index.transmission | 411 |
| abstract_inverted_index.Diagnostics), | 146 |
| abstract_inverted_index.Introduction: | 0 |
| abstract_inverted_index.bioMérieux), | 101 |
| abstract_inverted_index.confirmation, | 226 |
| abstract_inverted_index.transmission. | 398 |
| abstract_inverted_index.twice-monthly | 124 |
| abstract_inverted_index.(MALDI-TOF-MS) | 177 |
| abstract_inverted_index.Identification | 155 |
| abstract_inverted_index.time-of-flight | 174 |
| abstract_inverted_index.matrix-assisted | 171 |
| abstract_inverted_index.prevention/control | 423 |
| abstract_inverted_index.multidrug-resistant | 24 |
| abstract_inverted_index.desorption/ionization | 173 |
| abstract_inverted_index.healthcare-associated | 8 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 18 |
| citation_normalized_percentile.value | 0.08490612 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |